BMJ  2004;328:3-4 (3 January), doi:10.1136/bmj.328.7430.3

Editorial

Treatment of major depressive disorder in children and adolescents

Most selective serotonin reuptake inhibitors are no longer recommended

The first 150 words of the full text of this article appear below.

On 10 December 2003 Professor Gordon Duff, chairman of the Committee on Safety of Medicines in the United Kingdom, advised that most of the antidepressant drugs in the selective serotonin reuptake inhibitor group should not be used to treat major depressive disorder in children and adolescents under the age of 18 years.¹ This is the main category of medication used in the treatment of depression in children and adolescents, and the announcement will have taken many young people who take these drugs, their parents, and doctors by surprise. Although the advice only applies to the United Kingdom, it mirrors concerns that are also being considered by the US Food and Drug Administration.²

The new advice follows the review of data from clinical trials by an expert working group, convened initially because of concerns that selective serotonin reuptake inhibitors may increase the risk of suicidal thoughts and self harm in young . . . [Full text of this article]

Section of Child and Adolescent Psychiatry, University of Oxford Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX (paul.ramchandani@psych.ox.ac.uk)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Regulator restricts use of SSRIs in children

Lynn Eaton
BMJ 2005 330: 984. [Extract] [Full Text]

Increase in non-evidence based use of antidepressants in children is cause for concern

Antonio Clavenna, Maurizio Bonati, Elisa Rossi, and Marisa De Rosa
BMJ 2004 328: 711-712. [Extract] [Full Text]

Treating major depression in children and adolescents: Research is needed into safer and more effective drugs

Macey L Murray, Ian C K Wong, and Corinne S de Vries
BMJ 2004 328: 524-525. [Extract] [Full Text]

Treating major depression in children and adolescents: Depressed adolescents may lose out

Kenneth D Shenderey
BMJ 2004 328: 525. [Extract] [Full Text]

Treating major depression in children and adolescents: Use of selective serotonin reuptake inhibitors needs urgent clarification

Andrew Herxheimer
BMJ 2004 328: 525. [Extract] [Full Text]

A tough time for paediatricians

Richard Smith
BMJ 2004 328: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Timimi, S. (2008). Child psychiatry and its relationship with the pharmaceutical industry: theoretical and practical issues. Adv. Psychiatr. Treat. 14: 3-9 [Abstract] [Full text]  
• Biddle, L., Gunnell, D., Donovan, J., Sharp, D. (2006). Young adults' reluctance to seek help and use medications for mental distress. J. Epidemiol. Community Health 60: 426-426 [Full text]  
• Warden, S. J., Robling, A. G., Sanders, M. S., Bliziotes, M. M., Turner, C. H. (2005). Inhibition of the Serotonin (5-Hydroxytryptamine) Transporter Reduces Bone Accrual during Growth. Endocrinology 146: 685-693 [Abstract] [Full text]  
• Prasad, S (2005). A new paradigm for developing drugs in children: atomoxetine as a model. Arch. Dis. Child. 90: i13-i16 [Abstract] [Full text]  
• Eaton, L. (2004). Agency warns of withdrawal risks for patients taking SSRIs. BMJ 329: 1365-1365 [Full text]  
• Timimi, S. (2004). Rethinking childhood depression. BMJ 329: 1394-1396 [Full text]  
• Kickbusch, I. (2004). From charity to rights: proposal for five action areas of global health. J. Epidemiol. Community Health 58: 630-631 [Full text]  
• Clavenna, A., Bonati, M., Rossi, E., De Rosa, M. (2004). Increase in non-evidence based use of antidepressants in children is cause for concern. BMJ 328: 711-712 [Full text]  
• Shenderey, K. D (2004). Treating major depression in children and adolescents: Depressed adolescents may lose out. BMJ 328: 525-525 [Full text]  
• Murray, M. L, Wong, I. C K, de Vries, C. S (2004). Treating major depression in children and adolescents: Research is needed into safer and more effective drugs. BMJ 328: 524-525 [Full text]  
• Herxheimer, A. (2004). Treating major depression in children and adolescents: Use of selective serotonin reuptake inhibitors needs urgent clarification. BMJ 328: 525-525 [Full text]  

Rapid Responses:

Read all Rapid Responses

Antidepressants in children and adolescents

Andrew Herxheimer
bmj.com, 3 Jan 2004 [Full text]

Prescribing trends of antidepressants in children and adolescents

Macey L Murray, et al.
bmj.com, 5 Jan 2004 [Full text]

SSRIs in Children

Mark Abramowicz, MD
bmj.com, 7 Jan 2004 [Full text]

More debate on the concept of childhood depression needed

Sami Timimi
bmj.com, 7 Jan 2004 [Full text]

Caution needed for tricyclic prescribing in depressed adolescents

Bernadka W Dubicka, et al.
bmj.com, 7 Jan 2004 [Full text]

Fish oil in depression

Edmond V O`Flaherty
bmj.com, 8 Jan 2004 [Full text]

Fish oil

Lisa C Blakemore-Brown
bmj.com, 8 Jan 2004 [Full text]

Treatment of major depressive disorder in children and adolescents: even more caution should be considered.

Federico Marchetti, et al.
bmj.com, 9 Jan 2004 [Full text]

Will Depressed Adolescents Lose Out?

Kenneth D Shenderey
bmj.com, 9 Jan 2004 [Full text]

TWO MORE LESSONS TO BE LEARNT

Robert M Wrate
bmj.com, 19 Jan 2004 [Full text]

A suicide is a process

Sergio A. Pérez Barrero
bmj.com, 23 Jan 2004 [Full text]

Clarity or obfuscation in antidepressant trials?

Hans A de Haan, et al.
bmj.com, 7 Feb 2004 [Full text]

SSRIs in Young People

Gillian Baird, et al.
bmj.com, 16 Feb 2004 [Full text]